Evidence map›Paper›PMID 19814743›Full record

ArticleAlimentary pharmacology & therapeutics2010

The assessment of regional gut transit times in healthy controls and patients with gastroparesis using wireless motility technology.

I Sarosiek, K H Selover, L A Katz, J R Semler, G E Wilding, J M Lackner, M D Sitrin, B Kuo, W D Chey, W L Hasler and 4 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Alimentary pharmacology & therapeutics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02573519 (Gastrointestinal Motility Among Diabetes Patients), which is not on this map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02573519 naterminatednot on this mapstarted 2015, after this paper: background citation

Gastrointestinal Motility Among Diabetes Patients

TypeinterventionalSponsorUniversity of AarhusRan2015 to 2019Enrolled40ConditionsDiabetic Autonomic Neuropathy, Gastrointestinal Motility Disorder, Diabetes Mellitus, Change of Transit or CirculationArms11C Donepezil PET/CT scan, 3D-Transit, 3D-Transit during treatment with Pyridostigmine, 3D-Transit after Malone appendicostomy
3 · Its place in the literature

Who cites it

60 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Ten controversies in gastroparesis and a look to the future.Neurogastroenterology and motility · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

I SarosiekCenter for Gastrointestinal Nerve & Muscle Function & GI Motility, University of Kansas Medical Center, Kansas City, USA. Irene.sarosiek@ttuhsc.edu
K H Selover
L A Katz
J R Semler
G E Wilding
J M Lackner
M D Sitrin
B Kuo
W D Chey
W L Hasler
K L Koch
H P Parkman
J Sarosiek
R W McCallum

Funding

Functional Dyspepsia: Defining Central CircuitsK23DK069614 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI KUO, BRADEN · 2005 to 2009
$670k
NIDDK NIH HHS DK069614NIDDK NIH HHS K23 DK069614
6 · The paper itself

Abstract

backgroundWireless pH and pressure motility capsule (wireless motility capsule) technology provides a method to assess regional gastrointestinal transit times.

aimsTo analyse data from a multi-centre study of gastroparetic patients and healthy controls and to compare regional transit times measured by wireless motility capsule in healthy controls and gastroparetics (GP).

methodsA total of 66 healthy controls and 34 patients with GP (15 diabetic and 19 idiopathic) swallowed wireless motility capsule together with standardized meal (255 kcal). Gastric emptying time (GET), small bowel transit time (SBTT), colon transit time (CTT) and whole gut transit time (WGTT) were calculated using the wireless motility capsule.

resultsGastric emptying time, CTT and WGTT but not SBTT were significantly longer in GP than in controls. Eighteen percent of gastroparetic patients had delayed WGTT. Both diabetic and idiopathic aetiologies of gastroparetics had significantly slower WGTT (P < 0.0001) in addition to significantly slower GET than healthy controls. Diabetic gastroparetics additionally had significantly slower CTT than healthy controls (P = 0.0054).

conclusionsIn addition to assessing gastric emptying, regional transit times can be measured using wireless motility capsule. The prolongation of CTT in gastroparetic patients indicates that dysmotility beyond the stomach in GP is present, and it could be contributing to symptom presentation.

Indexed as

AdolescentAdultAgedCapsule EndoscopyColonFemaleGastrointestinal MotilityGastrointestinal TransitGastroparesisHumansMaleMiddle AgedMonitoring, Physiologic

Identifiers

PMID19814743
PMCPMC4444219

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.